-+ 0.00%
-+ 0.00%
-+ 0.00%

NeOnc Technologies Signs MoU With Abu Dhabi's Health Department Over Development Research And Clinical Capability In Oncology, Centrla Nervous System Therapeutics

Benzinga·10/21/2026 12:02:54
Listen to the news

NeOnc Technologies Holdings, Inc. (Nasdaq: NTHI) ("NeOnc" or the "Company"), a clinical-stage biopharmaceutical company developing therapies for central nervous system (CNS) cancers, today announced that it has signed a Memorandum of Understanding (MoU) with the Department of Health – Abu Dhabi (DoH) to cooperate on the development of research and clinical capability in oncology and central nervous system therapeutics in the Emirate of Abu Dhabi. The MoU was signed on the sidelines of the Abu Dhabi Future Health Summit (ADFHS) 2026.